AwardedSpainGoods€2,595,136
2025-10 Suministro del medicamento con principio activo exclusivo REMDESIVIR de la empresa Gilead Sciences Ireland Unlimited Company.
- Published
- Published 14 July 2025
Overview
Suministro del medicamento con principio activo exclusivo REMDESIVIR de la empresa Gilead Sciences Ireland Unlimited Company.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,595,136
- Procedure
- Direct
- Published
- 14 July 2025
Pharmaceutical products
Award outcome
- Awarded value
- €961,162
- Award date
- 11 June 2025
- Contract period
- 11 June 2025 → 10 July 2027
- GILEAD SCIENCES, S.L.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
14 July 2025
Contracting authority
CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB)
Procuring entityBARCELONA, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.